Sodium Butyrate vs Tributyrin: An Honest Comparison of Butyrate Forms (2026)
Sodium butyrate is butyric acid bound to sodium and releases butyrate early in digestion. Tributyrin is three butyrate molecules on a glycerol backbone and needs pancreatic lipase to cut them free. L-lysine butyrate binds it to an amino acid. In a 2025 randomized crossover trial of 10 healthy men, lysine butyrate peaked in serum at 4.53 µg/mL at 20 minutes, roughly 5 times tributyrin's peak. Lysine butyrate and sodium butyrate did not differ significantly.
This is the two-form matchup. Our full butyrate supplement guide compares all three forms and grades every benefit claim by species.
Key takeaways
- Sodium butyrate is a salt, tributyrin is a triglyceride
- L-lysine butyrate is the third form, bound to an amino acid
- One human trial measured all three forms in serum
- Lysine and sodium butyrate tied; both beat tributyrin
- Human outcome data on butyrate is still genuinely mixed
What's the actual difference between sodium butyrate and tributyrin?
Both deliver butyrate, a short-chain fatty acid your gut bacteria already make when they ferment fiber. The chemistry of how that butyrate is packaged is where they split.
“I can smell the butyrate but it goes away once it's mixed with water. It tastes good and it works. It really cuts down my appetite. I'll be ordering more!”
Sodium butyrate is butyric acid paired with sodium. It's a salt, it's water-soluble, and it comes apart quickly once it hits fluid. That's why so many sodium butyrate products are sold as enteric-coated capsules or microencapsulated beads: the raw powder would release most of its payload before it got anywhere interesting.
Tributyrin is an oil. Three butyrate molecules sit on a glycerol backbone, exactly like any dietary fat, and pancreatic lipase has to cleave them off before the butyrate is free. That extra step is the entire pitch: slower release, delivered further down.
There's a third option you'll see less often, which is butyrate bound to an amino acid instead of a mineral or a fat. That's the form we use, and I'll get to why below.
If you want the broader picture of what butyrate does before comparing forms, I wrote a longer butyrate forms breakdown that covers the mechanism in more depth.
Does tributyrin really survive the stomach?
This is the claim you'll see on nearly every tributyrin label, and it deserves a harder look.
A 2023 human crossover trial in men with overweight or obesity ran a nice experiment on the way to its main result. Before dosing anyone, the researchers put tributyrin through a validated model of the stomach and small intestine. Tributyrin was rapidly cleaved in the gastric compartment, not the small intestine (van Deuren et al., 2023).
Plain tributyrin came apart early. Only when the researchers esterified the butyrate with long-chain fatty acids did release shift downstream into the small intestine.
So the "survives the stomach intact" story is doing more work in ad copy than in the lab model. That doesn't make tributyrin bad. It means the delivery advantage is more conditional than the label implies.
Ozzi uses L-Lysine Butyrate (BIOMEnd) at 500mg per stick: butyrate bound to an amino acid rather than sodium or a glycerol backbone, mixed into cold water instead of swallowed as a capsule.
Plain tributyrin got cleaved in the stomach compartment, not the small intestine. The label says otherwise.
Most of the flattering tributyrin research is preclinical. Tributyrin supported intestinal barrier markers and tight junction proteins in mice exposed to alcohol (Cresci et al., 2017), in mice given antibiotics (Yang et al., 2023), and again in mice alongside human intestinal cell work (Siddiqui et al., 2024). Earlier mouse work paired it with a probiotic and saw similar patterns (Cresci et al., 2013).
Rodents are not small people. Their gut transit, microbiome, and fat digestion all differ from ours. This literature is full of mouse findings quoted as human fact, and the gut-supplement category is one of the worst offenders.
The one genuine head-to-head comparison of forms I could find compared microencapsulated sodium butyrate against tributyrin in black sea bream (Ullah et al., 2025). Interesting for aquaculture. Not something I'd build a human recommendation on.
What has oral butyrate actually been tested on in humans?
Here's the section most butyrate brands skip. Everything below involved participants who were patients under medical care, studied for medical outcomes, so read it as background on the molecule rather than as anything about a daily wellness drink.
The honest summary: results are all over the map.
| Study population | Form | Result |
|---|---|---|
| Adults with type 1 diabetes | Sodium butyrate | Fecal butyrate rose. Immune measures unchanged. |
| Children with IBD | Sodium butyrate | No benefit over placebo at 12 weeks. |
| Adults with type 2 diabetes | Sodium butyrate | Mostly null. Some unfavorable lipid shifts. |
| Adults with fatty liver disease | Sodium vs calcium butyrate | Primary endpoint unchanged in both arms. |
| Adults with IBD | Microencapsulated sodium butyrate | Shifted gut bacteria toward SCFA producers. |
| Children with obesity | Sodium butyrate | Positive across several measures. |
The type 1 diabetes trial is the most useful one for settling a basic question (de Groot et al., 2020). Oral butyrate measurably raised fecal butyrate and propionate, which confirms the stuff arrives. It just didn't move the immune outcomes they were looking for.
The pediatric IBD trial found nothing over placebo (Pietrzak et al., 2022). The type 2 diabetes trial was largely null and flagged some unfavorable cholesterol movement worth knowing about (Khosravi et al., 2022).
A 2025 trial compared sodium butyrate against calcium butyrate in 181 adults with fatty liver disease and found no change in the primary endpoint for either salt (Mitrović et al., 2025). That's the closest thing we have to a form-versus-form human comparison, and it came back a tie at zero.
On the encouraging side, microencapsulated sodium butyrate shifted the gut microbiome toward butyrate-producing bacteria in adults with IBD (Facchin et al., 2020), and a pediatric obesity trial reported positive results across several markers (Coppola et al., 2022).
Six trials, three roughly positive, three roughly null. Anyone selling you certainty about butyrate forms is selling you something the literature hasn't earned yet.
What about GLP-1? Doesn't butyrate boost it?
I get this question constantly, and I want to be careful here because our own category is sloppy about it.
The GLP-1 story for butyrate is preclinical. In rodent and cell studies, butyrate stimulates L-cells in the intestinal lining, and those are the cells that release GLP-1. That's the proposed mechanism, and it's a reasonable one.
What we don't have is a human study showing butyrate raises GLP-1. The 2023 trial I mentioned earlier is the sharpest test of it: butyrate-enriched triglycerides did raise circulating butyrate in men with overweight or obesity, and GLP-1 was measured as a named secondary outcome. It did not change (van Deuren et al., 2023).
Circulating butyrate went up. GLP-1 stayed flat. That's the honest state of the human evidence.
So when you see a butyrate product claiming it boosts your GLP-1, that claim is running on mouse data. I'd rather tell you that than let you find out from a Reddit thread. For the fuller version, see butyrate and GLP-1 and our primer on what GLP-1 actually is.
Why does butyrate smell so bad, and does the form fix it?
Butyric acid is the compound behind the smell of rancid butter and parmesan left in a hot car. It's genuinely unpleasant, and it's the single biggest reason butyrate supplements are sold as capsules you swallow fast.
The form changes the experience a lot.
Sodium butyrate powder is the worst offender by smell. Tributyrin is an oil, so the butyrate is chemically tied up until digestion frees it, which mutes the odor considerably (softgels help too).
A free Sample Pack with your first order. Use code SAMPLE at checkout, or tap below and it applies itself.
Claim the free Sample PackBinding butyrate to an amino acid also blunts it. Nothing makes it disappear entirely. Anyone promising a completely neutral butyrate product is overselling.
Which butyrate form actually reaches your bloodstream?
This is the question the category mostly avoids, and in 2025 somebody finally ran it.
A randomized, single-blinded, three-arm crossover trial put sodium butyrate, L-lysine butyrate, and tributyrin head to head in 10 healthy men. Same butyric acid load in every arm, three visits at least a week apart, a 10-hour fast before each, and serum butyrate measured by mass spectrometry at 20, 45, 90, 150, and 210 minutes (La Monica et al., 2025).
Here's what came back.
| Form | Peak serum butyrate | Time to peak | Total exposure (AUC) |
|---|---|---|---|
| L-lysine butyrate | 4.53 µg/mL | 20 minutes | 189 |
| Sodium butyrate | 2.51 µg/mL | 22.5 minutes | 144 |
| Tributyrin | 0.91 µg/mL | 51.5 minutes | 108 |
Two things matter here, and one of them is a result our own marketing doesn't get to use.
Both salts beat tributyrin, clearly. Lysine butyrate hit a peak roughly 5 times higher than tributyrin's and got there about 30 minutes sooner (p=0.007 for peak, p=0.004 for timing). Sodium butyrate beat tributyrin too.
Lysine butyrate did not beat sodium butyrate. The raw averages look like it did. The statistics say otherwise (p=0.340 for peak, p=0.660 for total exposure). Person-to-person variation was enormous, larger than the averages themselves, which the authors attribute to hyper responders. On absorption, the two salts tie, and anyone showing you those raw numbers without the p-values is selling something.
Every man in the lysine butyrate arm peaked at exactly 20 minutes. Zero variance on timing.
Be careful what you take from this. It's 10 men, one dose, a 210-minute window, and no clinical outcomes of any kind. It's a pharmacokinetic pilot, which answers "does it get in" and says nothing about "does it do anything." Anyone quoting it as proof that a butyrate product works is misreading it.
Why does getting butyrate into your blood matter at all?
Fair pushback: butyrate's home turf is the colon, so why chase blood levels?
Because the colon consumes nearly everything it makes. Colonocytes burn roughly 95% of colon-produced butyrate as fuel, and the liver clears most of what survives on first pass. Only about 2% of gut-derived butyrate reaches peripheral circulation.
Butyrate's wider signaling, HDAC inhibition and the FFAR2 and FFAR3 receptors, happens in tissues outside the gut wall: liver, muscle, blood vessels, immune cells. Those targets only ever see butyrate that made it into circulation.
So a category optimizing hard for colonic delivery is optimizing for the compartment with the tightest ceiling. That's the argument, and it's why we care what a form does in serum rather than what its label says about the colon.
Being fair to tributyrin: slow release deeper in the gut is a real design goal, not a failure to absorb. If colonic butyrate is what you're after, that delayed profile is the feature you're paying for. The two forms are built for different jobs.
What about L-lysine butyrate, the form in Ozzi?
We use L-lysine butyrate (BIOMEnd), which binds butyrate to the amino acid L-lysine rather than to sodium or a glycerol backbone. Ozzi has 500mg per stick.
Three things put it ahead for our purposes.
It ties the best absorber and skips the sodium. Sodium butyrate matches it in serum, but it brings sodium along every single serving. Lysine butyrate carries none, because the counter-ion is an amino acid instead of a mineral.
It's the most drinkable of the three. Palatability testing in that same trial rated lysine butyrate the most tolerable form. That matters more than it sounds. Butyrate's smell is the entire reason this category lives inside capsules, and a form you'll actually drink every day beats a better form you quit in a week.
It works in cold water. Sodium butyrate handles poorly in a drink stick. That's a formulation constraint rather than a biological one, and it's why so much butyrate ends up in a pill you swallow fast.
Now the limits, said plainly. There is no human outcome trial on L-lysine butyrate. The 2025 study is a pharmacokinetic pilot in 10 men, it measured absorption and nothing else, and it was funded in part by an industry institute. That is not proof that lysine butyrate produces a health result, and I won't call it clinically proven, because it hasn't earned that word.
What I can tell you honestly is that butyrate is the primary energy source for the cells lining your colon, and that we pair it with chicory root inulin, a prebiotic fiber that feeds butyrate-producing bacteria. Direct butyrate plus fuel for your own bacteria to make more. That combination is the design logic, and you can read more about the food-first version in how to increase butyrate naturally.
Which butyrate form should you actually pick?
There's finally enough evidence to answer this on absorption and practicality. Outcomes remain an open question for all three.
Overall pick: L-lysine butyrate. It matches the best-absorbing form in the only human trial that compared them, carries no sodium, rated the most palatable, and works in a drink instead of a capsule. It's the form we use, so weigh that accordingly, but the reasoning is on the table for you to check.
Sodium butyrate is the value pick, and it has more human trial exposure than the other two combined. It absorbed just as well. Look for microencapsulated or enteric-coated versions, since those are what the better human studies used, and watch the sodium if you're tracking it.
Tributyrin is the pick if your goal is butyrate further down the gut rather than in circulation, or if you want a softgel and you're sensitive to smell. Know going in that most of its supporting research is preclinical and that it came last in serum.
| Form | Serum absorption | Sodium | Best for |
|---|---|---|---|
| L-lysine butyrate | Highest measured, tied with sodium butyrate | None | Daily use in a drink, sodium-conscious |
| Sodium butyrate | Tied with lysine butyrate | Yes, every serving | Deepest human trial record, lowest cost |
| Tributyrin | Lowest of the three | None | Colon-targeted delivery, softgel format |
And if your interest in butyrate is really about gut health generally, food does a lot of this work. Fiber feeds the bacteria that produce butyrate in the amounts your colon evolved to expect. Our pieces on gut health and GLP-1 and leaky gut and inflammation go deeper there.
Where do cravings and food noise fit into this?
Most people who email me about butyrate forms aren't actually asking a chemistry question. They're asking whether any of it will quiet the food noise at 9pm.
Fair question, so here's my honest answer. Butyrate form is a minor variable compared to whether you're eating enough fiber and protein, sleeping, and managing stress. The gut-brain signaling that shapes appetite is real and worth understanding (the gut-brain axis covers it), and it's slower and less dramatic than supplement marketing suggests.
Ozzi puts butyrate alongside allulose, glucomannan, inulin, African mango, and chromium, because appetite has more than one lever. Butyrate alone was never going to carry it.
Frequently asked questions
Is tributyrin better than sodium butyrate?
Not on absorption. A 2025 human crossover trial measured both in serum, and sodium butyrate reached a peak roughly 3 times higher, about 30 minutes sooner. No human trial has compared them on a health outcome.
Which butyrate form absorbs best?
In the only human trial that measured all three, L-lysine butyrate and sodium butyrate absorbed comparably and both beat tributyrin. Lysine butyrate peaked at 4.53 µg/mL at 20 minutes against 0.91 µg/mL for tributyrin. The gap between the two salts was not statistically significant.
Does butyrate raise GLP-1?
In rodent and cell studies, butyrate stimulates the L-cells that release GLP-1. In the human trial that measured GLP-1 as a secondary outcome while successfully raising circulating butyrate, GLP-1 did not change.
Which butyrate form smells the least?
Tributyrin in a softgel is generally the least noticeable, since the butyrate stays bound until digestion. Raw sodium butyrate powder is the strongest. No form is odorless.
Is sodium butyrate bad for blood pressure?
The sodium in a typical serving is small relative to a normal diet, but it's a real consideration if you're on a sodium-restricted plan. Amino-acid-bound and triglyceride forms avoid it entirely.
Can I just eat fiber instead?
For most people, yes, and it's the better starting point. Your gut bacteria produce butyrate from fermentable fiber. Supplements are a supplement to that, not a replacement.
How long does butyrate take to work?
Human trials that showed changes ran for weeks to months, not days. Anyone promising a next-day effect from butyrate specifically is guessing.
Is L-lysine butyrate clinically proven?
No. There's one human randomized crossover trial on it, and it measured absorption only, in 10 men, on a single dose. No human trial has tested it against a health outcome. We chose it for absorption, sodium load, and palatability, and I'd rather say that plainly than imply evidence that doesn't exist.
Are there side effects?
Reported effects in trials were mild and infrequent, mostly transient nausea or headache. One type 2 diabetes trial noted unfavorable cholesterol shifts, which is worth discussing with your doctor if you have lipid concerns.
Should I take butyrate with food?
Tributyrin needs pancreatic lipase, which is most active during a meal containing fat, so taking it with food makes mechanistic sense. Other forms are less dependent on meal timing.
Butyrate you can actually drink
Ozzi Crave Crusher puts 500mg of L-lysine butyrate in a cold-water stick with allulose, glucomannan, inulin, and chromium. No capsules to swallow. No caffeine.
Try it for 14 days straight. If it doesn't work, we'll refund your first bag.
References
- La Monica MB, Kirby T, Hartshorn SL, Gustat A, Grdic J, Sandrock J. A Pharmacokinetic Comparison of Three Butyrate Products. Journal of Exercise and Nutrition. 2025;8(1):4. NCT06700785 (human)
- van Deuren T, et al. Butyrate and hexanoate-enriched triglycerides increase postprandial systemic butyrate and hexanoate in men with overweight/obesity. Frontiers in Nutrition. 2023. https://doi.org/10.3389/fnut.2022.1066950 (human)
- Mitrović M, et al. Exploring the Potential of Oral Butyrate Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences. 2025. https://doi.org/10.3390/ijms26125561 (human)
- de Groot PF, et al. Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes. Diabetologia. 2020. https://doi.org/10.1007/s00125-019-05073-8 (human)
- Pietrzak A, et al. Sodium Butyrate Effectiveness in Children and Adolescents with Newly Diagnosed Inflammatory Bowel Diseases. Nutrients. 2022. https://doi.org/10.3390/nu14163283 (human)
- Khosravi Z, et al. The effects of butyrate supplementation on glycemic control, lipid profile, blood pressure, nitric oxide level and glutathione peroxidase activity in type 2 diabetic patients. Clinical Nutrition ESPEN. 2022. https://doi.org/10.1016/j.clnesp.2022.03.008 (human)
- Facchin S, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterology & Motility. 2020. https://doi.org/10.1111/nmo.13914 (human)
- Coppola S, et al. Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial. JAMA Network Open. 2022. https://doi.org/10.1001/jamanetworkopen.2022.44912 (human)
- Yang N, et al. Tributyrin alleviates gut microbiota dysbiosis to repair intestinal damage in antibiotic-treated mice. PLoS One. 2023. https://doi.org/10.1371/journal.pone.0289364 (rodent)
- Cresci GA, et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. Journal of Gastroenterology and Hepatology. 2017. https://doi.org/10.1111/jgh.13731 (rodent and in vitro)
- Siddiqui MT, et al. The Postbiotic Butyrate Mitigates Gut Mucosal Disruption Caused by Acute Ethanol Exposure. International Journal of Molecular Sciences. 2024. https://doi.org/10.3390/ijms25031665 (rodent and human cell)
- Cresci G, et al. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. JPEN. 2013. https://doi.org/10.1177/0148607113486809 (rodent)
- Ullah S, et al. Comparative Effects of Dietary Supplementations with Microencapsulated Sodium Butyrate, Glycerol Monolaurate and Tributyrin. Animals. 2025. https://doi.org/10.3390/ani15060810 (fish)
Research sourced via PubMed.
